Revvity
Karen Sear is an experienced professional in quality management and scientific research with a career spanning over two decades. Currently serving as the Director of Quality Management IDx at Revvity since September 2023, Karen has held the position of Director, Quality at Oxford Immunotec since April 2007, overseeing quality management for an IVD product manufacturer. Previous roles include Research Scientist at BioVex Ltd, Research Assistant at MRC Harwell, Scientific Assistant/Laboratory Supervisor at Oxagen Ltd, and Research Technician at MRC Harwell. Karen holds a BSc (Honours) degree in Biological Sciences from The Open University and has completed A-levels in Human Biology, Chemistry, Economics, and General Studies at King Alfred's sixth form.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com